All attending UK organisations

UK companies attending  as part of the official delegation

(Click here to search profiles):

UK Exhibitors
BioPartner UK: UK stand, booth 82; Life Sciences in the Northern Powerhouse, booth 83/84; Syne qua non, booth 89a.

Cobra Biologics, Enplas Europe Limited, Evaluate Ltd, FUJIFILM Diosynth Biotechnologies, GlobalData Plc, Pharma Intelligence Informa, LifeArc, Pharma Intelligence Informa, Sekisui, Symbiosis Pharmaceutical Services, Watson-Marlow Fluid Technology Group, 

UK stand (booth 82) and Regional Groups:
United Life Sciences, Scottish Development International, NIHR Clinical Research Network, PHASTAR.

ARCINOVA, CIMYM Biosciences, Clinical Network Services (UK), Crystec, Datatrial, High Force Research, IDACO Consulting, Image Analysis Group, Inivata, Karma Oncology, Medherant, Microbiotica, MicroMatrices Associates, Mironid, NIHR Clinical Research Network, OBN UK, Oncimmune, One Nucleus, Oxstem, Scottish Development International, Selcia, Syne qua non, SYNthesis Research, Ubiquigent, United Life Sciences (BIA, Bionow, Biopartner UK, MediWales, One Nucleus).

Life Sciences in the Northern Powerhouse:
APTUS CLINICAL, Bionow, Health Innovation Manchester, Manchester Science Partnership, Northern Health Science Alliance, Seda Pharmaceutical Development Services.

Scotland: Censo Biotechnologies, Karma Oncology, MicroMatrices Associates, Mironid, Scottish Development International, Synpromics, Tepnel Pharma Services, Ubiquigent.

UK Presenting Companies and PanellistsChugai Pharmaceuticals, EUSA Pharma, F-star, Informa, Informa, Isogenica, Johnson & Johnson Innovation, MSD, Mundipharma International, Oxford Biotherapeutics, QuintilesIMS, Reviral, Touchstone Innovations.

All attending UK companies:
Abingworth, Accenture Accelerated R&D Services, Accord Healthcare Ltd, ADC Therapeutics, AGales Consulting, Albumedix, Alliance pharmaceuticals, Almac Discovery, AMR Centre, Animalcare, Apex Healthcare Consulting, Apitope International, Aptus Clinical, ARCINOVA, Arix Bioscience, Artemida Pharma, Aspire Pharma, Autolus, Avacta Life Sciences, Avillion LLP, Barrington James, BenevolentAI, BioLinking, Bionow, BioPartner UK, Biopharma Group, Boult Wade Tennant, C4X Discovery Holdings, Cancer Research Technology, Cancer Research UK, Cell & Gene Therapy Catapult, Cell Medica, Cello Health, Certara Simcyp, Champion Oncology, Chronos Therapeutics, CIMYM Biosciences, Circassia Pharmaceuticals, Citigate Dewe Rogerson, Clarivate Analytics, Clinical Accelerator, Clinical Network Services (UK), Clinigen Group, CN Bio Innovations, Colliers International Property, Concept Life Sciences, Congenica, Consilient Health, Coulter Partners, Covance Inc, CRA International UK, Crescendo Biologics, Cresset Discovery Services, Crystec, Cyclacel, Datatrial, Decision Resources Group, Destiny Pharma, Diamond Pharma Services, Dishman Europe, Domainex, DRG Abacus, Drug Discovery Unit, e Therapeutics plc, EBD Academy, Edinburgh Molecular Imaging, Elasmogen Ltd, Emstopa, Enesi Pharma, Enplas, Enterprise Therapeutics, Epidarex Capital, ERA Consulting UK, ERGOMED PLC, e-Therapeutics, Eurotechnologies, EUSA Pharma, Evaluate, Evernow Publishing Ltd, Evotec, Exscientia, Femeda, Ferghana Partners, F-star Biotechnology, FUJIFILM Diosynth Biotechnologies, Fusion Antibodies, GBI Research, GE Healthcare, GlobalData, Glythera, Gowling WLG (UK), Haoma Medica, HC Pharma Consultancy, Heptares Therapeutics, High Force Research, HORIBA UK, IDACO Consulting, Image Analysis Group, ImmuPharma, Inceptua Medicines Access, IGEM Therapeutics, Informa, Inivata, Instinctif Partners, IOmet Pharma/MSD, Iontas, Ipsen Biopharm, Isogenica, Janssen-Cilag Spa, Jazz Pharmaceuticals, JJDC, Johnson & Johnson Innovation, Kaiser Associates, Karma Oncology, Keosys, King's College London, KWS BioTest, Kymab, Life Sciences in the Northern Powerhouse, LifeArc, LIFNano Therapeutics, Locke Lord (UK), Macrophage Pharma, Mallinckrodt Pharmaceuticals, Manchester Science Partnerships, Mawdsleys, MedCity, Medherant, Medicxi, Medius Associates, MediWales, MedPharm, Mereo BioPharma Group, Mergermarket, Microbiotica, MicroMatrices Associates, Midatech, Mironid, Mission Therapeutics, Mitsubishi Tanabe Pharma Europe, Morgan Prestwich, MVM Partners, Naked Ideas, Nanogenic Solutions, Nanomerics, Nature Research, Neem Biotech, NIHR Clinical Research Network, Norgine, Norgine Ventures, Northern Health Science Alliance, OBN UK, Oncimmune, One Nucleus, Ono Pharma UK, Oppilotech, Orbit Discovery, Ossianix, Oxford Biotherapeutics, Oxford Genetics, Oxstem, Patheon- a Thermo Fisher company, PatSnap, PCI Clinical Services, Pharmalicensing, Pharma Intelligence, PharmaVentures, PharmaWave, Phastar, Plexus Ventures, PPD, Premier Research, ProAxsis, Procarta Biosystems, Proimmune, Prokarium, Propath UK, PsiOxus Therapeutics, Pure Communications, Queen Mary Innovation, QuintilesIMS, Randox Laboratories, Redx Pharma, Results Healthcare, ReViral, Rosemont  - Perrigo, Rothschild & Co, Sagentia, Samedan  - EBR, Sareum,, Scottish Development International, Scrip & The Pink Sheet, Seda Pharmaceutical Development Services, Sekisui, Selcia, Sentinel Oncology, Sharp Clinical Services, Sidley Austin, Silence Therapeutics, Silicon Valley Bank, Simbec Orion, SiSaf, Sixth Element Capital, SmartAnalyst, Spencer Stuart, SpringerNature, SPYBIOTECH, Storm Therapeutics, Stratophase, Substipharm, Summit Therapeutics, Sygnature Discovery, Symbiosis Pharmaceutical Services, Syncona, Syne qua non, Synpromics, Synpromics, SYNthesis Research, Taylor & Francis, TCRS, Teijin Pharma, Tepnel Pharma Services, The Fulford Group, The Institute of Cancer Research, The Sage Group, The University Of Manchester, Theradex Europe, Tissue Solutions, Touchstone Innovations, TranScrip, Treehill Partners, Tusk Therapeutics, Ubiquigent, UK BioIndustry Association (BIA), Ulster University, ValiSeek, VCLS, Vectura, Vernalis, Viramal Limited, Warwick Ventures, 3M United Kingdom Plc.

Join them here!